The antibody, called 04_A06, blocked 98.5% of more than 300 different HIV strains in lab tests, including many resistant to ...

A Long Island woman had no idea what had hit her. Her pursuit of an answer led to a mosquito-borne disease rarely seen in the ...

According to Dr Neel Patel from LloydsPharmacy Online Doctor, telling one apart form the other may be key as the cooler ...

With Eli Lilly's recent acquisition of Verve Therapeutics and its PCSK9 candidate, delve into what the target represents.

Increased daily liveweight gain, respiratory health issues driven down by 75% and antibiotic use down 60% are the result of ...

The refusal of blood transfusions by Jehovah’s Witnesses poses a major challenge in treating acute myeloid leukaemia (AML), ...

Researchers have engineered a rare type of immune cell to kill slow-growing bowel cancer cells that are resistant to current therapies.

New data suggest that early peanut exposure may cut the risk of allergic reactions. Newsweek asked experts what parents ...

A KILDARE man is running his first ever marathon in honour of his “incredible” wife who was diagnosed with end stage kidney ...

Susan Galbraith, Ph.D., AZ’s oncology R&D chief, attributed Datroway’s strong efficacy to its ADC construct, specifically its ...

Novo Nordisk is paying $240 million up front for global rights to zaltenibart, an Omeros drug that blocks the MASP-3 protein to treat diseases caused by excessive activity of the complement system.

Chances are, you may know a family living with food allergies. Food allergies are more prevalent than many realize, ...